14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 PBYI stock ended at $4.62. This is 4.94% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 12.06% from a day low at $4.36 to a day high of $4.88.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Puma Biotechnology Inc prices

Date Open High Low Close Volume
May 06, 2024 $4.85 $4.88 $4.36 $4.62 583 440
May 03, 2024 $5.10 $5.26 $4.81 $4.86 388 031
May 02, 2024 $4.97 $4.97 $4.77 $4.96 319 771
May 01, 2024 $5.05 $5.17 $4.90 $4.95 255 933
Apr 30, 2024 $4.97 $5.07 $4.84 $5.07 225 820
Apr 29, 2024 $5.12 $5.15 $4.95 $5.02 200 157
Apr 26, 2024 $4.87 $5.11 $4.87 $5.02 167 402
Apr 25, 2024 $4.78 $5.06 $4.72 $4.88 229 936
Apr 24, 2024 $5.09 $5.13 $4.77 $4.83 309 785
Apr 23, 2024 $5.17 $5.34 $5.10 $5.13 292 944
Apr 22, 2024 $5.01 $5.27 $5.00 $5.17 263 410
Apr 19, 2024 $4.92 $5.08 $4.90 $5.01 263 320
Apr 18, 2024 $5.18 $5.29 $4.93 $4.99 285 630
Apr 17, 2024 $5.10 $5.30 $5.05 $5.17 247 084
Apr 16, 2024 $5.32 $5.42 $5.06 $5.10 275 594
Apr 15, 2024 $5.30 $5.43 $5.25 $5.35 225 425
Apr 12, 2024 $5.37 $5.50 $5.21 $5.27 221 254
Apr 11, 2024 $5.51 $5.65 $5.46 $5.49 138 014
Apr 10, 2024 $5.77 $5.80 $5.40 $5.53 330 635
Apr 09, 2024 $5.61 $6.06 $5.59 $5.83 549 469
Apr 08, 2024 $5.64 $5.71 $5.44 $5.63 296 457
Apr 05, 2024 $5.49 $5.84 $5.42 $5.66 402 244
Apr 04, 2024 $5.40 $5.57 $5.36 $5.51 516 758
Apr 03, 2024 $5.24 $5.35 $5.10 $5.35 334 103
Apr 02, 2024 $5.16 $5.33 $5.05 $5.28 375 221
Click to get the best stock tips daily for free!

About Puma Biotechnology Inc

Puma Biotechnology Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance... PBYI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT